Work

Combined KIT and CTLA-4 blockade in patients with refractory GIST and other advanced sarcomas.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.10521

Authors: Alexander Noor Shoushtari, Sandra P. D'Angelo, Mary Louise Keohan, Mark Andrew Dickson, Mrinal M. Gounder, Abdul Karim Abdullah, Joseph Patrick Erinjeri, Mark J. Bluth, Yelena Ustoyev, Mercedes M. Condy, Howard Streicher, Naoko Takebe, Ronald P. DeMatteo, Gary K. Schwartz, William D. Tap, Richard D. Carvajal

Institutions: Memorial Sloan Kettering Cancer Center, National Cancer Institute, Columbia University Irving Medical Center

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603638259

Cites:

Cited by: 12

Related to: 10